Related Articles
Involvement of p53 R72P polymorphism in the association of MDM2-SNP309 with breast cancer
MDM2 SNP309 modifies the prognostic significance of the p53 mutational status in patients with ovarian cancer
Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer
Association of MDM2 promoter T309G polymorphism with oral cancer risk: A meta-analysis of 3,536 subjects
Single‑nucleotide polymorphism (c.309T>G) in the MDM2 gene and lung cancer risk